Researcher.Life Logo

Anales del Jardin Botanico de Madrid : Impact Factor & More

eISSN: 1988-3196pISSN: 0211-1322
JournalOpen Access

Key Metrics

CiteScore
1.1
H-Index
24
Impact Factor
< 5
SJR
Q4Plant Science
SNIP
0.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Anales del Jardin Botanico de Madrid Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher CONSEJO SUPERIOR INVESTIGACIONES CIENTIFICAS-CSIC
Language Spanish,English
Frequency Semi-annual
Publication Time48
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageSpanish,English
FrequencySemi-annual
Publication Start Year1940
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 48
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo,Dulcinea
License typeCC BY
OA statementVisit website
View less

Planning to publish in Anales del Jardin Botanico de Madrid ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Anales del Jardin Botanico de Madrid

Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities.
  • 1 Aug 2026
  • Biochemical pharmacology
Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling.
  • 1 Aug 2026
  • Biochemical pharmacology
Tucatinib alleviates postmenopausal osteoporosis by suppressing osteoclast differentiation via regulating the DRP1/NFATc1/CTSK signaling pathway.
  • 1 Aug 2026
  • Biochemical pharmacology
Retraction notice to "Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway" [Biochem. Pharmacol. 243 (2026) 117489
  • 1 Aug 2026
  • Biochemical pharmacology
β-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
  • 1 Aug 2026
  • Biochemical pharmacology
NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression.
  • 1 Aug 2026
  • Biochemical pharmacology
Disrupting E3 ubiquitin ligase protein-protein interactions in cancer: chemical modalities, mechanisms, and therapeutic opportunities.
  • 1 Aug 2026
  • Biochemical pharmacology
Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling.
  • 1 Aug 2026
  • Biochemical pharmacology
Tucatinib alleviates postmenopausal osteoporosis by suppressing osteoclast differentiation via regulating the DRP1/NFATc1/CTSK signaling pathway.
  • 1 Aug 2026
  • Biochemical pharmacology
Retraction notice to "Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway" [Biochem. Pharmacol. 243 (2026) 117489
  • 1 Aug 2026
  • Biochemical pharmacology
β-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
  • 1 Aug 2026
  • Biochemical pharmacology
NPTX2 accelerates cell cycle progression, activates EMT, and regulates glycolytic metabolic pathways to promote clear cell renal cell carcinoma progression.
  • 1 Aug 2026
  • Biochemical pharmacology

FAQs on Anales del Jardin Botanico de Madrid